70
Participants
Start Date
January 31, 2012
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Ranibizumab
Intra-vitreal injections of 0.5mg/0.05 mL dosage, injected at months 0, 1, and 2. For those requiring additional injections, patients will receive monthly treatment up to a maximum of 6 months total.
St. Joseph's Healthcare Hamilton Regional Eye Centre, Hamilton
Toronto Western Hospital Eye Clinic, Toronto
Canadian National Institute for the Blind
OTHER
McMaster University
OTHER